Links between electrophysiological and molecular pathology of amyotrophic lateral sclerosis

Integrative and Comparative Biology

Volumn 51, Issue 6, 2011, Pages 913-925

  Quinlan, Katharina A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM BINDING PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; GLUTAMIC ACID; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; ASTROCYTE; CONFERENCE PAPER; DISEASE MODEL; ELECTROPHYSIOLOGY; ENDOPLASMIC RETICULUM; ENZYMOLOGY; GENETICS; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MOTONEURON; MOUSE; NERVE CONDUCTION; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; PROTEIN DEGRADATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ASTROCYTES; CALCIUM; CALCIUM-BINDING PROTEINS; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGICAL PHENOMENA; ENDOPLASMIC RETICULUM; GLUTAMIC ACID; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MOTOR NEURONS; NEURAL CONDUCTION; PROTEOLYSIS; STRESS, PHYSIOLOGICAL; SUPEROXIDE DISMUTASE;

EID: 82255181339     PISSN: 15407063     EISSN: 15577023     Source Type: Journal    
DOI: 10.1093/icb/icr116     Document Type: Conference Paper

References (167)

1. Ackerley S, Grierson AJ, Banner S, Perkinton MS, Brownlees J, Byers HL, Ward M, Thornhill P, Hussain K, Waby JS, Anderton BH, Cooper JD, Dingwall C, Leigh PN, Shaw CE, Miller CC. 2004. p38alpha stress-activated protein kinase phosphorylates neurofilaments and is associated with neurofilament pathology in amyotrophic lateral sclerosis. Mol Cell Neurosci 26:354-64. (Pubitemid 38781091)
2. Ackerley S, Grierson AJ, Brownlees J, Thornhill P, Anderton BH, Leigh PN, Shaw CE, Miller CC. 2000. Glutamate slows axonal transport of neurofilaments in transfected neurons. J Cell Biol 150:165-76.
3. Alaburda A, Perrier JF, Hounsgaard J. 2002. Mechanisms causing plateau potentials in spinal motoneurones. Adv Exp Med Biol 508:219-26. (Pubitemid 34953747)
4. Alexianu ME, Kozovska M, Appel SH. 2001. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57:1282-9. (Pubitemid 32947389)
5. Amendola J, Durand J. 2008. Morphological differences between wild-type and transgenic superoxide dismutase 1 lumbar motoneurons in postnatal mice. J Comp Neurol 511:329-41.
6. Amendola J, Verrier B, Roubertoux P, Durand J. 2004. Altered sensorimotor development in a transgenic mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 20:2822-6. (Pubitemid 39573798)
7. Azbill RD, Mu X, Springer JE. 2000. Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes. Brain Res 871:175-80. (Pubitemid 30433869)
8. Bayliss DA, Umemiya M, Berger AJ. 1995. Inhibition of N- and P-type calcium currents and the afterhyperpolarization in rat motoneurones by serotonin. J Physiol 485:635-47.
9. Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR, Appel SH. 2006. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 103:16021-6. (Pubitemid 44657585)
10. Bellingham MC. 2011. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?. CNS Neurosci Ther 17:4-31.
11. Bendotti C, Tortarolo M, Suchak SK, Calvaresi N, Carvelli L, Bastone A, Rizzi M, Rattray M, Mennini T. 2001. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem 79:737-46. (Pubitemid 33086511)
12. Bensimon G, Lacomblez L, Meininger V. 1994. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/ Riluzole Study Group. N Engl J Med 330:585-91. (Pubitemid 24065791)
13. Bergmann F, Keller BU. 2004. Impact of mitochondrial inhibition on excitability and cytosolic Ca2+ levels in brainstem motoneurones from mouse. J Physiol 555:45-59. (Pubitemid 38324500)
14. Bernasconi R, Molinari M. 2011. ERAD and ERAD tuning: disposal of cargo and of ERAD regulators from the mammalian ER. Curr Opin Cell Biol 23:176-83.
15. Bilsland LG, Nirmalananthan N, Yip J, Greensmith L, Duchen MR. 2008. Expression of mutant SOD1 in astrocytes induces functional deficits in motoneuron mitochondria. J Neurochem 107:1271-83.
16. Bilsland LG, Sahai E, Kelly G, Golding M, Greensmith L, Schiavo G. 2010. Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci USA 107:20523-8.
17. Bingol B, Sheng M. 2011. Deconstruction for reconstruction: the role of proteolysis in neural plasticity and disease. Neuron 69:22-32.
18. Blankenship AG, Feller MB. 2010. Mechanisms underlying spontaneous patterned activity in developing neural circuits. Nat Rev Neurosci 11:18-29.
19. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW. 2006. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312:1389-92. (Pubitemid 43839552)
20. Bories C, Amendola J, Lamotte d'Incamps B, Durand J. 2007. Early electrophysiological abnormalities in lumbar motoneurons in a transgenic mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 25:451-9.
21. Brownlees J, Yates A, Bajaj NP, Davis D, Anderton BH, Leigh PN, Shaw CE, Miller CC. 2000. Phosphorylation of neurofilament heavy chain side-arms by stress activated protein kinase-1b/Jun N-terminal kinase-3. J Cell Sci 113(Pt 3):401-7. (Pubitemid 30116647)
22. Bruijn LI, Becher MW, Lee MK, Anderson KL, Jenkins NA, Copeland NG, Sisodia SS, Rothstein JD, Borchelt DR, Price DL, Cleveland DW. 1997. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327-38. (Pubitemid 27111114)
23. Byrne S, Walsh C, Lynch C, Bede P, Elamin M, Kenna K, McLaughlin R, Hardiman O. 2011. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 82:623-7.
24. Campbell MJ, McComas AJ, Petito F. 1973. Physiological changes in ageing muscles. J Neurol Neurosurg Psychiatry 36:174-82.
25. Carunchio I, Curcio L, Pieri M, Pica F, Caioli S, Viscomi MT, Molinari M, Canu N, Bernardi G, Zona C. 2010. Increased levels of p70S6 phosphorylation in the G93A mouse model of Amyotrophic Lateral Sclerosis and in valine-exposed cortical neurons in culture. Exp Neurol 226:218-30.
26. Chen S, Owens GC, Crossin KL, Edelman DB. 2007. Serotonin stimulates mitochondrial transport in hippocampal neurons. Mol Cell Neurosci 36:472-83. (Pubitemid 47633971)
27. Chen S, Owens GC, Edelman DB. 2008. Dopamine inhibits mitochondrial motility in hippocampal neurons. PLoS One 3:e2804.
28. Chiu IM, Chen A, Zheng Y, Kosaras B, Tsiftsoglou SA, Vartanian TK, Brown RH Jr, Carroll MC. 2008. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS. Proc Natl Acad Sci USA 105:17913-8.
29. Chiu IM, Phatnani H, Kuligowski M, Tapia JC, Carrasco MA, Zhang M, Maniatis T, Carroll MC. 2009. Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. Proc Natl Acad Sci USA 106:20960-5.
30. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, Rule M, McMahon AP, Doucette W, Siwek D, Ferrante RJ, Brown RH Jr, Julien JP, Goldstein LS, Cleveland DW. 2003. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302:113-7. (Pubitemid 37210700)
31. Dal Canto MC, Gurney ME. 1994. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 145:1271-9. (Pubitemid 24378480)
32. Dal Canto MC, Gurney ME. 1995. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res 676:25-40.
33. Damiano M, Starkov AA, Petri S, Kipiani K, Kiaei M, Mattiazzi M, Flint Beal M, Manfredi G. 2006. Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice. J Neurochem 96:1349-61.
34. De Vos KJ, Chapman AL, Tennant ME, Manser C, Tudor EL, Lau KF, Brownlees J, Ackerley S, Shaw PJ, McLoughlin DM, Shaw CE, Leigh PN, Miller CC, Grierson AJ. 2007. Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum Mol Genet 16:2720-8. (Pubitemid 350018514)
35. De Vos KJ, Grierson AJ, Ackerley S, Miller CC. 2008. Role of axonal transport in neurodegenerative diseases. Annu Rev Neurosci 31:151-73.
36. Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, Yang Y, Fecto F, Shi Y, Zhai H, Jiang H, Hirano M, Rampersaud E, Jansen GH, Donkervoort S, Bigio EH, Brooks BR, Ajroud K, Sufit RL, Haines JL, Mugnaini E, Pericak-Vance MA, Siddique T. 2011. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477:211-5.
37. Duch C, Vonhoff F, Ryglewski S. 2008. Dendrite elongation and dendritic branching are affected separately by different forms of intrinsic motoneuron excitability. J Neurophysiol 100:2525-36.
38. Elbasiouny SM, Amendola J, Durand J, Heckman CJ. 2010. Evidence from computer simulations for alterations in the membrane biophysical properties and dendritic processing of synaptic inputs in mutant superoxide dismutase-1 motoneurons. J Neurosci 30:5544-58.
39. Fierro L, Llano I. 1996. High endogenous calcium buffering in Purkinje cells from rat cerebellar slices. J Physiol 496(Pt 3):617-25. (Pubitemid 26387847)
40. Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA, Glass JD. 2004. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 185:232-40. (Pubitemid 38084849)
41. Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P. 2000. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20:2534-42. (Pubitemid 30220340)
42. Gonzalez-Islas C, Wenner P. 2006. Spontaneous network activity in the embryonic spinal cord regulates AMPAergic and GABAergic synaptic strength. Neuron 49:563-75. (Pubitemid 43221891)
43. Gowing G, Philips T, Van Wijmeersch B, Audet JN, Dewil M, Van Den Bosch L, Billiau AD, Robberecht W, Julien JP. 2008. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase. J Neurosci 28:10234-44.
44. Gurney ME, Cutting FB, Zhai P, Doble A, Taylor CP, Andrus PK, Hall ED. 1996. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 39:147-57. (Pubitemid 26071564)
45. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, Caliendo J, Hentati A, Kwon YW, Deng HX, et al. 1994. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772-5. (Pubitemid 24227760)
46. Hebert T, Drapeau P, Pradier L, Dunn RJ. 1994. Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole. Mol Pharmacol 45:1055-60. (Pubitemid 24155800)
47. Heckman CJ, Johnson M, Mottram C, Schuster J. 2008. Persistent inward currents in spinal motoneurons and their influence on human motoneuron firing patterns. Neuroscientist 14:264-75. (Pubitemid 351624860)
48. Heckman CJ, Kuo JJ, Johnson MD. 2004. Synaptic integration in motoneurons with hyper-excitable dendrites. Canadian journal of physiology and pharmacology 82:549-55. (Pubitemid 40065100)
49. Hegedus J, Putman CT, Gordon T. 2007. Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 28:154-64. (Pubitemid 47615455)
50. Hegedus J, Putman CT, Tyreman N, Gordon T. 2008. Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol 586:3337-51. (Pubitemid 352003870)
51. Hiruma H, Katakura T, Takahashi S, Ichikawa T, Kawakami T. 2003. Glutamate and amyloid beta-protein rapidly inhibit fast axonal transport in cultured rat hippocampal neurons by different mechanisms. J Neurosci 23:8967-77. (Pubitemid 37210910)
52. Hounsgaard J, Hultborn H, Jespersen B, Kiehn O. 1988. Bistability of alpha-motoneurones in the decerebrate cat and in the acute spinal cat after intravenous 5-hydroxytryptophan. J Physiol 405:345-67.
53. Hounsgaard J, Kiehn O. 1989. Serotonin-induced bistability of turtle motoneurones caused by a nifedipinesensitive calcium plateau potential. J Physiol Lond 414:265-82. (Pubitemid 19177302)
54. Hsiao CF, Del Negro CA, Trueblood PR, Chandler SH. 1998. Ionic basis for serotonin-induced bistable membrane properties in guinea pig trigeminal motoneurons. J Neurophysiol 79:2847-56.
55. Hultborn H, Brownstone RB, Toth TI, Gossard JP. 2004. Key mechanisms for setting the input-output gain across the motoneuron pool. Prog Brain Res 143:77-95. (Pubitemid 37442983)
56. Ignacio S, Moore DH, Smith AP, Lee NM. 2005. Effect of neuroprotective drugs on gene expression in G93A/SOD1 mice. Ann N Y Acad Sci 1053:121-36. (Pubitemid 43031089)
57. Ilieva HS, Yamanaka K, Malkmus S, Kakinohana O, Yaksh T, Marsala M, Cleveland DW. 2008. Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death. Proc Natl Acad Sci USA 105:12599-604.
58. Israelson A, Arbel N, Da Cruz S, Ilieva H, Yamanaka K, Shoshan-Barmatz V, Cleveland DW. 2010. Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 67:575-87.
59. Jaiswal MK, Keller BU. 2009. Cu/Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of mitochondria and perturbs Ca2+ homeostasis in SOD1G93A mice. Mol Pharmacol 75:478-89.
60. Jaiswal MK, Zech WD, Goos M, Leutbecher C, Ferri A, Zippelius A, Carri MT, Nau R, Keller BU. 2009. Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease. BMC Neurosci 10:64.
61. Jiang M, Schuster JE, Fu R, Siddique T, Heckman CJ. 2009. Progressive changes in synaptic inputs to motoneurons in adult sacral spinal cord of a mouse model of amyotrophic lateral sclerosis. J Neurosci 29:15031-8.
62. Jiang Z, Rempel J, Li J, Sawchuk MA, Carlin KP, Brownstone RM. 1999. Development of L-type calcium channels and a nifedipine-sensitive motor activity in the postnatal mouse spinal cord. Eur J Neurosci 11:3481-7. (Pubitemid 29484245)
63. Johnston JA, Dalton MJ, Gurney ME, Kopito RR. 2000. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 97:12571-6.
64. Kaiser M, Maletzki I, Hulsmann S, Holtmann B, Schulz- Schaeffer W, Kirchhoff F, Bahr M, Neusch C. 2006. Progressive loss of a glial potassium channel (KCNJ10) in the spinal cord of the SOD1 (G93A) transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem 99:900-12. (Pubitemid 44583449)
65. Kawahara Y, Ito K, Sun H, Aizawa H, Kanazawa I, Kwak S. 2004. Glutamate receptors: RNA editing and death of motor neurons. Nature 427:801.
66. Kawahara Y, Sun H, Ito K, Hideyama T, Aoki M, Sobue G, Tsuji S, Kwak S. 2006. Underediting of GluR2 mRNA, a neuronal death inducing molecular change in sporadic ALS, does not occur in motor neurons in ALS1 or SBMA. Neurosci Res 54:11-4. (Pubitemid 41785347)
67. Kawasaki H, Morooka T, Shimohama S, Kimura J, Hirano T, Gotoh Y, Nishida E. 1997. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem 272:18518-21. (Pubitemid 27318185)
68. Kennel PF, Finiels F, Revah F, Mallet J. 1996. Neuromuscular function impairment is not caused by motor neurone loss in FALS mice: an electromyographic study. Neuroreport 7:1427-31. (Pubitemid 26281007)
69. Kieran D, Hafezparast M, Bohnert S, Dick JR, Martin J, Schiavo G, Fisher EM, Greensmith L. 2005. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol 169:561-7. (Pubitemid 41002849)
70. Kim TY, Kim E, Yoon SK, Yoon JB. 2008. Herp enhances ER-associated protein degradation by recruiting ubiquilins. Biochem Biophys Res Commun 369:741-6.
71. Kong J, Xu Z. 1998. Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. J Neurosci 18:3241-50. (Pubitemid 28186017)
72. Kuo JJ, Siddique T, Fu R, Heckman CJ. 2005. Increased persistent Na+ current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J Physiol-London 563:843-54. (Pubitemid 40425599)
73. Kwak S, Kawahara Y. 2005. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis. J Mol Med (Berl) 83:110-20. (Pubitemid 40379299)
74. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Powe L, Durrleman S, Delumeau JC, Meininger V. 1996. A confirmatory dose-ranging study of riluzole in ALS. ALS/Riluzole Study Group-II. Neurology 47:S242-50. (Pubitemid 26422577)
75. Ladewig T, Lalley PM, Keller BU. 2004. Serotonergic modulation of intracellular calcium dynamics in neonatal hypoglossal motoneurons from mouse. Brain Res 1001:1-12. (Pubitemid 38221523)
76. Landmesser LT, O'Donovan MJ. 1984. Activation patterns of embryonic chick hind limb muscles recorded in ovo and in an isolated spinal cord preparation. J Physiol 347:189-204. (Pubitemid 14058505)
77. Lauriat TL, Richler E, McInnes LA. 2007. A quantitative regional expression profile of EAAT2 known and novel splice variants reopens the question of aberrant EAAT2 splicing in disease. Neurochem Int 50:271-80. (Pubitemid 44879685)
78. Lee CH, Inoki K, Guan KL. 2007. mTOR pathway as a target in tissue hypertrophy. Annu Rev Pharmacol 47:443-67.
79. Lee MS, Kwon YT, Li M, Peng J, Friedlander RM, Tsai LH. 2000. Neurotoxicity induces cleavage of p35 to p25 by calpain. Nature 405:360-4. (Pubitemid 30337070)
80. Lee RH, Heckman CJ. 1999. Enhancement of bistability in spinal motoneurons in vivo by the noradrenergic alpha1 agonist methoxamine. J Neurophysiol 81:2164-74. (Pubitemid 29262550)
81. Li Q, Vande Velde C, Israelson A, Xie J, Bailey AO, Dong MQ, Chun SJ, Roy T, Winer L, Yates JR, Capaldi RA, Cleveland DW, Miller TM. 2010. ALS-linked mutant superoxide dismutase 1 (SOD1) alters mitochondrial protein composition and decreases protein import. Proc Natl Acad Sci USA 107:21146-51.
82. Li X, Murray K, Harvey PJ, Ballou EW, Bennett DJ. 2007. Serotonin facilitates a persistent calcium current in motoneurons of rats with and without chronic spinal cord injury. J Neurophysiol 97:1236-46. (Pubitemid 46239501)
83. Li Y, Li X, Harvey PJ, Bennett DJ. 2004. Effects of baclofen on spinal reflexes and persistent inward currents in motoneurons of chronic spinal rats with spasticity. J Neurophysiol 92:2694-703. (Pubitemid 40340482)
84. Lim PJ, Danner R, Liang J, Doong H, Harman C, Srinivasan D, Rothenberg C, Wang H, Ye Y, Fang S, Monteiro MJ. 2009. Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD. J Cell Biol 187:201-17.
85. Lips MB, Keller BU. 1998. Endogenous calcium buffering in motoneurones of the nucleus hypoglossus from mouse. J Physiol 511(Pt 1):105-17. (Pubitemid 28421316)
86. Lobsiger CS, Boillee S, McAlonis-Downes M, Khan AM, Feltri ML, Yamanaka K, Cleveland DW. 2009. Schwann cells expressing dismutase active mutant SOD1 unexpectedly slow disease progression in ALS mice. Proc Natl Acad Sci USA 106:4465-70.
87. MacAskill AF, Atkin TA, Kittler JT. 2010. Mitochondrial trafficking and the provision of energy and calcium buffering at excitatory synapses. Eur J Neurosci 32:231-40.
88. MacAskill AF, Rinholm JE, Twelvetrees AE, Arancibia-Carcamo IL, Muir J, Fransson A, Aspenstrom P, Attwell D, Kittler JT. 2009. Miro1 is a calcium sensor for glutamate receptor-dependent localization of mitochondria at synapses. Neuron 61:541-55.
89. Mackenzie IR, Rademakers R, Neumann M. 2010. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol 9:995-1007.
90. Maragakis NJ, Dykes-Hoberg M, Rothstein JD. 2004. Altered expression of the glutamate transporter EAAT2b in neurological disease. Ann Neurol 55:469-77. (Pubitemid 38391963)
91. Marder E, Rehm KJ. 2005. Development of central pattern generating circuits. Curr Opin Neurobiol 15:86-93. (Pubitemid 40249966)
92. Marks JD, Donnelly DF, Haddad GG. 1993. Adenosineinduced inhibition of vagal motoneuron excitability: receptor subtype and mechanisms. Am J Physiol 264:L124-32. (Pubitemid 23079465)
93. Mattiazzi M, D'Aurelio M, Gajewski CD, Martushova K, Kiaei M, Beal MF, Manfredi G. 2002. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J Biol Chem 277:29626-33. (Pubitemid 41079252)
94. Mattson MP, Gleichmann M, Cheng A. 2008. Mitochondria in neuroplasticity and neurological disorders. Neuron 60:748-66.
95. McCue HV, Haynes LP, Burgoyne RD. 2010. The diversity of calcium sensor proteins in the regulation of neuronal function. Cold Spring Harb Perspect Biol 2:a004085.
96. Meehan CF, Moldovan M, Marklund SL, Graffmo KS, Nielsen JB, Hultborn H. 2010. Intrinsic properties of lumbar motor neurones in the adult G127insTGGG superoxide dismutase-1 mutant mouse in vivo: evidence for increased persistent inward currents. Acta Physiol (Oxf) 200:361-76.
97. Miles GB, Parkis MA, Lipski J, Funk GD. 2002. Modulation of phrenic motoneuron excitability by ATP: consequences for respiratory-related output in vitro. J Appl Physiol 92:1899-910. (Pubitemid 34666417)
98. Miller RG, Bouchard JP, Duquette P, Eisen A, Gelinas D, Harati Y, Munsat TL, Powe L, Rothstein J, Salzman P, Sufit RL. 1996. Clinical trials of riluzole in patients with ALS. ALS/Riluzole Study Group-II. Neurology 47:S86-90. discussion S90-82.
99. Mironov SL. 2007. ADP regulates movements of mitochondria in neurons. Biophys J 92:2944-52. (Pubitemid 46557867)
100. Mogyoros I, Kiernan MC, Burke D, Bostock H. 1998. Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis. Brain 121(Pt 5):851-9. (Pubitemid 28220893)
101. Moreno-Lopez B, Sunico CR, Gonzalez-Forero D. 2011. NO orchestrates the loss of synaptic boutons from adult "sick" motoneurons: modeling a molecular mechanism. Mol Neurobiol 43:41-66.
102. Mourelatos Z, Gonatas NK, Stieber A, Gurney ME, Dal Canto MC. 1996. The Golgi apparatus of spinal cord motor neurons in transgenic mice expressing mutant Cu,Zn superoxide dismutase becomes fragmented in early, preclinical stages of the disease. Proc Natl Acad Sci USA 93:5472-7. (Pubitemid 26159474)
103. Munch C, Ebstein M, Seefried U, Zhu B, Stamm S, Landwehrmeyer GB, Ludolph AC, Schwalenstocker B, Meyer T. 2002. Alternative splicing of the 5'-sequences of the mouse EAAT2 glutamate transporter and expression in a transgenic model for amyotrophic lateral sclerosis. J Neurochem 82:594-603. (Pubitemid 34831497)
104. Mynlieff M, Beam KG. 1994. Adenosine acting at an A1 receptor decreases N-type calcium current in mouse motoneurons. J Neurosci 14:3628-34. (Pubitemid 24174111)
105. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S. 2007. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10:615-22. (Pubitemid 46652435)
106. Neher E. 1995. The use of fura-2 for estimating Ca buffers and Ca fluxes. Neuropharmacology 34:1423-42.
107. Nguyen KT, Garcia-Chacon LE, Barrett JN, Barrett EF, David G. 2009. The Psi(m) depolarization that accompanies mitochondrial Ca2+ uptake is greater in mutant SOD1 than in wild-type mouse motor terminals. Proc Natl Acad Sci USA 106:2007-11.
108. Ozdinler PH, Benn S, Yamamoto TH, Guzel M, Brown RH Jr, Macklis JD. 2011. Corticospinal motor neurons and related subcerebral projection neurons undergo early and specific neurodegeneration in hSOD1G(3)A transgenic ALS mice. J Neurosci 31:4166-77.
109. Palecek J, Lips MB, Keller BU. 1999. Calcium dynamics and buffering in motoneurones of the mouse spinal cord. J Physiol 520 Pt 2:485-502. (Pubitemid 29511912)
110. Pardo CA, Xu Z, Borchelt DR, Price DL, Sisodia SS, Cleveland DW. 1995. Superoxide dismutase is an abundant component in cell bodies, dendrites, and axons of motor neurons and in a subset of other neurons. Proc Natl Acad Sci USA 92:954-8.
111. Perrier JF, Delgado-Lezama R. 2005. Synaptic release of serotonin induced by stimulation of the raphe nucleus promotes plateau potentials in spinal motoneurons of the adult turtle. J Neurosci 25:7993-9. (Pubitemid 41254402)
112. Philips T, Robberecht W. 2011. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol 10:253-63.
113. Pieri M, Carunchio I, Curcio L, Mercuri NB, Zona C. 2009. Increased persistent sodium current determines cortical hyperexcitability in a genetic model of amyotrophic lateral sclerosis. Exp Neurol 215:368-79.
114. Pivovarova NB, Andrews SB. 2010. Calcium-dependent mitochondrial function and dysfunction in neurons. The FEBS journal 277:3622-36.
115. Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C, Kordasiewicz H, Sedaghat Y, Donohue JP, Shiue L, Bennett CF, Yeo GW, Cleveland DW. 2011. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 14:459-68.
116. Powers RK, Binder MD. 2001. Input-output functions of mammalian motoneurons. Rev Physiol Biochem Pharmacol 143:137-263.
117. Pun S, Santos AF, Saxena S, Xu L, Caroni P. 2006. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 9:408-19. (Pubitemid 43290971)
118. Quinlan KA, Schuster JE, Fu R, Siddique T, Heckman CJ. 2011. Altered postnatal maturation of electrical properties in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis. J Physiol 589:2245-60.
119. Raoul C, Estevez AG, Nishimune H, Cleveland DW, deLapeyriere O, Henderson CE, Haase G, Pettmann B. 2002. Motoneuron death triggered by a specific pathway downstream of Fas. potentiation by ALS-linked SOD1 mutations. Neuron 35:1067-83. (Pubitemid 35279535)
120. Reaume AG, Elliott JL, Hoffman EK, Kowall NW, Ferrante RJ, Siwek DF, Wilcox HM, Flood DG, Beal MF, Brown RH Jr, Scott RW, Snider WD. 1996. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet 13:43-7. (Pubitemid 26139292)
121. Ren K, Ruda MA. 1994. A comparative study of the calcium-binding proteins calbindin-D28K, calretinin, calmodulin and parvalbumin in the rat spinal cord. Brain Res Brain Res Rev 19:163-79. (Pubitemid 24150317)
122. Rintoul GL, Bennett VJ, Papaconstandinou NA, Reynolds IJ. 2006. Nitric oxide inhibits mitochondrial movement in forebrain neurons associated with disruption of mitochondrial membrane potential. J Neurochem 97:800-6.
123. Rintoul GL, Filiano AJ, Brocard JB, Kress GJ, Reynolds IJ. 2003. Glutamate decreases mitochondrial size and movement in primary forebrain neurons. J Neurosci 23:7881-8. (Pubitemid 37052356)
124. Ron D, Walter P. 2007. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 8:519-29. (Pubitemid 46985379)
125. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX, et al. 1993. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362:59-62. (Pubitemid 23087289)
126. Rothstein JD. 1996. Excitotoxicity hypothesis. Neurology 47:S19-25. discussion S26.
127. Rothstein JD, Martin LJ, Kuncl RW. 1992. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326:1464-8.
128. Rothstein JD, Patel S, Regan MR, Haenggeli C, Huang YH, Bergles DE, Jin L, Dykes Hoberg M, Vidensky S, Chung DS, Toan SV, Bruijn LI, Su ZZ, Gupta P, Fisher PB. 2005. Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433:73-7. (Pubitemid 40101145)
129. Sasaki S, Warita H, Abe K, Komori T, Iwata M. 2001. EAAT1 and EAAT2 immunoreactivity in transgenic mice with a G93A mutant SOD1 gene. Neuroreport 12:1359-62. (Pubitemid 32476129)
130. Saxena S, Cabuy E, Caroni P. 2009. A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci 12:627-36.
131. Saxena S, Caroni P. 2011. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron 71:35-48.
132. Schwarzschild MA, Cole RL, Hyman SE. 1997. Glutamate, but not dopamine, stimulates stress-activated protein kinase and AP-1-mediated transcription in striatal neurons. J Neurosci 17:3455-66. (Pubitemid 27200575)
133. Spitzer NC. 2006. Electrical activity in early neuronal development. Nature 444:707-12. (Pubitemid 44949593)
134. Stevenson A, Yates DM, Manser C, De Vos KJ, Vagnoni A, Leigh PN, McLoughlin DM, Miller CC. 2009. Riluzole protects against glutamate-induced slowing of neurofilament axonal transport. Neurosci Lett 454:161-4.
135. Sun H, Kawahara Y, Ito K, Kanazawa I, Kwak S. 2006. Slow and selective death of spinal motor neurons in vivo by intrathecal infusion of kainic acid: implications for AMPA receptormediated excitotoxicity in ALS. J Neurochem 98:782-91. (Pubitemid 44051279)
136. Swarup V, Phaneuf D, Bareil C, Robertson J, Rouleau GA, Kriz J, Julien JP. 2011. Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragments. Brain 134(Pt 9):2610-26.
137. Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, Konig J, Hortobagyi T, Nishimura AL, Zupunski V, Patani R, Chandran S, Rot G, Zupan B, Shaw CE, Ule J. 2011. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci 14:452-8.
138. Tomlinson BE, Irving D. 1977. The numbers of limb motor neurons in the human lumbosacral cord throughout life. J Neurol Sci 34:213-9. (Pubitemid 8188068)
139. Tortarolo M, Grignaschi G, Calvaresi N, Zennaro E, Spaltro G, Colovic M, Fracasso C, Guiso G, Elger B, Schneider H, Seilheimer B, Caccia S, Bendotti C. 2006. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease. J Neurosci Res 83:134-46. (Pubitemid 43062017)
140. Tortarolo M, Veglianese P, Calvaresi N, Botturi A, Rossi C, Giorgini A, Migheli A, Bendotti C. 2003. Persistent activation of p38 mitogen-activated protein kinase in a mouse model of familial amyotrophic lateral sclerosis correlates with disease progression. Mol Cell Neurosci 23:180-92. (Pubitemid 36703155)
141. Tortarolo M, Grignaschi G, Calvaresi N, Zennaro E, Spaltro G, Colovic M, Fracasso C, Guiso G, Elger B, Schneider H, Seilheimer B, Caccia S, Bendotti C. 2006. Glutamate AMPA receptors change in motor neurons of SOD1G93A transgenic mice and their inhibition by a noncompetitive antagonist ameliorates the progression of amytrophic lateral sclerosis-like disease. J Neurosci Res 83:134-46. (Pubitemid 43062017)
142. Turner BJ, Lopes EC, Cheema SS. 2003. Neuromuscular accumulation of mutant superoxide dismutase 1 aggregates in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci Lett 350:132-6. (Pubitemid 37101429)
143. Urbani A, Belluzzi O. 2000. Riluzole inhibits the persistent sodium current in mammalian CNS neurons. Eur J Neurosci 12:3567-74.
144. Van Damme P, Bogaert E, Dewil M, Hersmus N, Kiraly D, Scheveneels W, Bockx I, Braeken D, Verpoorten N, Verhoeven K, Timmerman V, Herijgers P, Callewaert G, Carmeliet P, Van Den Bosch L, Robberecht W. 2007. Astrocytes regulate GluR2 expression in motor neurons and their vulnerability to excitotoxicity. Proc Natl Acad Sci USA 104:14825-30. (Pubitemid 350003227)
145. Van Den Bosch L. 2011. Genetic rodent models of amyotrophic lateral sclerosis. J Biomed Biotechnol 2011:348765.
146. van Zundert B, Peuscher MH, Hynynen M, Chen A, Neve RL, Brown RH Jr, Constantine-Paton M, Bellingham MC. 2008. Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Neurosci 28:10864-10874.
147. Vanselow BK, Keller BU. 2000. Calcium dynamics and buffering in oculomotor neurones from mouse that are particularly resistant during amyotrophic lateral sclerosis (ALS)-related motoneurone disease. J Physiol 525(Pt 2):433-445. (Pubitemid 30398372)
148. Vinay L, Brocard F, Pflieger JF, Simeoni-Alias J, Clarac F. 2000. Perinatal development of lumbar motoneurons and their inputs in the rat. Brain Res Bull 53:635-47. (Pubitemid 32114316)
149. Vizard TN, O'Keeffe GW, Gutierrez H, Kos CH, Riccardi D, Davies AM. 2008. Regulation of axonal and dendritic growth by the extracellular calcium-sensing receptor. Nat Neurosci 11:285-91. (Pubitemid 351311792)
150. von Lewinski F, Fuchs J, Vanselow BK, Keller BU. 2008. Low Ca2+ buffering in hypoglossal motoneurons of mutant SOD1 (G93A) mice. Neurosci Lett 445:224-8.
151. von Lewinski F, Keller BU. 2005. Mitochondrial Ca2+ buffering in hypoglossal motoneurons from mouse. Neurosci Lett 380:203-8. (Pubitemid 40616080)
152. Vucic S, Kiernan MC. 2010. Upregulation of persistent sodium conductances in familial ALS. J Neurol Neurosurg Psychiatry 81:222-7.
153. Vucic S, Nicholson GA, Kiernan MC. 2008. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 131:1540-50. (Pubitemid 351806458)
154. Wagner OI, Lifshitz J, Janmey PA, Linden M, McIntosh TK, Leterrier JF. 2003. Mechanisms of mitochondrianeurofilament interactions. J Neurosci 23:9046-58.
155. Wang L, Sharma K, Grisotti G, Roos RP. 2009. The effect of mutant SOD1 dismutase activity on non-cell autonomous degeneration in familial amyotrophic lateral sclerosis. Neurobiol Dis 35:234-40.
156. Wang SJ, Wang KY, Wang WC. 2004. Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes). Neuroscience 125:191-201.
157. Warita H, Itoyama Y, Abe K. 1999. Selective impairment of fast anterograde axonal transport in the peripheral nerves of asymptomatic transgenic mice with a G93A mutant SOD1 gene. Brain Res 819:120-31. (Pubitemid 29225463)
158. Warita H, Manabe Y, Murakami T, Shiote M, Shiro Y, Hayashi T, Nagano I, Shoji M, Abe K. 2002. Tardive decrease of astrocytic glutamate transporter protein in transgenic mice with ALS-linked mutant SOD1. Neurological Res 24:577-81. (Pubitemid 35024486)
159. Williams A, Sarkar S, Cuddon P, Ttofi EK, Saiki S, Siddiqi FH, Jahreiss L, Fleming A, Pask D, Goldsmith P, O'Kane CJ, Floto RA, Rubinsztein DC. 2008. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat Chem Biol 4:295-305. (Pubitemid 351550888)
160. Williamson TL, Cleveland DW. 1999. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 2:50-6. (Pubitemid 30488940)
161. Wong PC, Cai H, Borchelt DR, Price DL. 2002. Genetically engineered mouse models of neurodegenerative diseases. Nat Neurosci 5:633-9. (Pubitemid 34742978)
162. Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL. 1995. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14:1105-16.
163. Xu W, Lipscombe D. 2001. Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines. J Neurosci 21:5944-51. (Pubitemid 32737727)
164. Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, Takahashi R, Misawa H, Cleveland DW. 2008. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci 11:251-3. (Pubitemid 351311795)
165. Yang Z, Klionsky DJ. 2010. Eaten alive: a history of macroautophagy. Nat Cell Biol 12:814-22.
166. Yi M, Weaver D, Hajnoczky G. 2004. Control of mitochondrial motility and distribution by the calcium signal: a homeostatic circuit. J Cell Biol 167:661-72. (Pubitemid 39565147)
167. Zhang B, Tu P, Abtahian F, Trojanowski JQ, Lee VM. 1997. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J Cell Biol 139:1307-15. (Pubitemid 27523216)